Insights And News

to power your pharmacy operation

Fighting back against 340B criticisms

Managed Healthcare Executive: Like many federally funded programs, the 340B Discount Drug program has become an easy target for those seeking to score political points, or for those lacking a full understanding of the purpose and merits of the program. Rising criticism from opponents has led to the possibility of the program being weakened or eliminated, compromising the healthcare of our country’s most vulnerable patients, the viability of the hospitals that serve them, and a healthcare system that is struggling to reign in costs, improve care and outcomes. 

read more

Posted: Saturday, August 29, 2020

Tags: Industry Articles